For a 100 mg target dose at 100 mg/mL: Volume to Draw = Desired DoseConcentration = 100 mg100 mg/mL = 1.0 mL Convert to syringe units
A method of preventing weakness in a patient with Parkinson's disease or of improving or restoring muscle strength of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said muscle strength, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where R] is one of an N-acyl group, a substituted or unsubstiruted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
Its function is bacteriostatic, meaning it inhibits the growth and reproduction of bacteria, which allows for safe, repeated withdrawals from the same vial
Nonetheless, the median lethal dose (LD50) can differ based on the species of animal and the method of administration (Wang et al., 2004)
